These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 26790669
1. Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients. Otsuka K, Imanishi Y, Tada Y, Kawakita D, Kano S, Tsukahara K, Shimizu A, Ozawa H, Okami K, Sakai A, Sato Y, Ueki Y, Sato Y, Hanazawa T, Chazono H, Ogawa K, Nagao T. Ann Surg Oncol; 2016 Jun; 23(6):2038-45. PubMed ID: 26790669 [Abstract] [Full Text] [Related]
2. [Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma]. Otsuka K, Imanishi Y, Habu N, Sato Y, Shigetomi S, Fujii R, Sakamoto K, Tomita T, Fujii M, Kameyama K, Ogawa K. Nihon Jibiinkoka Gakkai Kaiho; 2013 Sep; 116(9):1024-32. PubMed ID: 24191589 [Abstract] [Full Text] [Related]
6. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma. Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S. JAMA Otolaryngol Head Neck Surg; 2016 May 01; 142(5):489-95. PubMed ID: 26939990 [Abstract] [Full Text] [Related]
7. Prognostic factors and outcome analysis of salivary duct carcinoma. Han MW, Roh JL, Choi SH, Nam SY, Lee HJ, Cho KJ, Lee SW, Kim SY. Auris Nasus Larynx; 2015 Dec 01; 42(6):472-7. PubMed ID: 26028371 [Abstract] [Full Text] [Related]
8. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T. Cancer; 2005 Jun 15; 103(12):2526-33. PubMed ID: 15900577 [Abstract] [Full Text] [Related]
9. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland. Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H. J Otolaryngol Head Neck Surg; 2016 May 16; 45(1):32. PubMed ID: 27184361 [Abstract] [Full Text] [Related]
10. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands. Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF, PALGA Group, Jonker MA, Flucke UE, van Herpen CML. Int J Cancer; 2018 Aug 15; 143(4):758-766. PubMed ID: 29492965 [Abstract] [Full Text] [Related]
11. [Salivary duct carcinoma--a clinicopathological analysis of five cases]. Bień S, Sygut J, Kopczyński J, Postuła S, Ziółkowska M. Otolaryngol Pol; 2007 Aug 15; 61(1):33-8. PubMed ID: 17605416 [Abstract] [Full Text] [Related]
12. Clinical value of adjuvant therapy on the prognosis of ductal carcinoma of the major salivary gland: a large-scale cohort study. Zhang D, Li L, Wen T, Ma F. Eur Arch Otorhinolaryngol; 2023 Jan 15; 280(1):409-417. PubMed ID: 36036273 [Abstract] [Full Text] [Related]
13. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis. Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Erber R, Iro H, Fietkau R, Agaimy A. Strahlenther Onkol; 2017 Nov 15; 193(11):961-970. PubMed ID: 28828496 [Abstract] [Full Text] [Related]
15. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma. Qian K, Di L, Guo K, Zheng X, Ji Q, Wang Z. J Oral Maxillofac Surg; 2018 Jul 15; 76(7):1578-1586. PubMed ID: 29544756 [Abstract] [Full Text] [Related]
16. Brain metastases in patients with salivary duct carcinoma: A retrospective study. Fushimi C, Takahashi H, Kawakita D, Kano S, Tsukahara K, Ozawa H, Okami K, Sakai A, Yamazaki K, Okada T, Hanazawa T, Sato Y, Imanishi Y, Shimizu A, Matsuki T, Nagao T, Tada Y. Cancer Med; 2024 Mar 15; 13(5):e7037. PubMed ID: 38477487 [Abstract] [Full Text] [Related]
17. [Salivary duct carcinoma of the sublingual gland--a case report]. Sartorius C, Gille F, Bédrossian-Pfingsten J, Kempf HG. Laryngorhinootologie; 2006 Jul 15; 85(7):517-9. PubMed ID: 16586279 [Abstract] [Full Text] [Related]
18. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA, Tjho-Heslinga RE, de Jong JM, Roodenburg JL, Dutch Head and Neck Oncology Cooperative Group. Head Neck; 2004 Aug 15; 26(8):681-92; discussion 692-3. PubMed ID: 15287035 [Abstract] [Full Text] [Related]
19. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A. Hum Pathol; 2019 Nov 15; 93():37-47. PubMed ID: 31437521 [Abstract] [Full Text] [Related]
20. [Clinicopathological analysis of 40 cases of salivary duct carcinoma]. Lin N, Cai JH, Xu MJ, Kang P, Cheng ZF, He W. Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Jun 09; 54(6):416-419. PubMed ID: 31177683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]